987 related articles for article (PubMed ID: 15296889)
21. [Antifibrinolytic agents and repeat open-heart surgery: a comparison of tranexamic acid and low dose aprotinin].
Ait Houssa M; Selkane C; Amahzoune B; El Bekkali Y; Wahid FA; Moutaki Allah Y; Boulahya A; Ibat D; Drissi M; Azendour H; Elkirat A
Ann Cardiol Angeiol (Paris); 2007 Dec; 56(6):308-12. PubMed ID: 17976511
[TBL] [Abstract][Full Text] [Related]
22. Thromboelastography-based transfusion algorithm reduces blood product use after elective CABG: a prospective randomized study.
Ak K; Isbir CS; Tetik S; Atalan N; Tekeli A; Aljodi M; Civelek A; Arsan S
J Card Surg; 2009; 24(4):404-10. PubMed ID: 19583608
[TBL] [Abstract][Full Text] [Related]
23. Intravenous tranexamic acid use in myomectomy: a prospective randomized double-blind placebo controlled study.
Caglar GS; Tasci Y; Kayikcioglu F; Haberal A
Eur J Obstet Gynecol Reprod Biol; 2008 Apr; 137(2):227-31. PubMed ID: 17499419
[TBL] [Abstract][Full Text] [Related]
24. The use of tranexamic acid to reduce postoperative bleeding following cardiac surgery: a double-blind randomized trial.
Coffey A; Pittmam J; Halbrook H; Fehrenbacher J; Beckman D; Hormuth D
Am Surg; 1995 Jul; 61(7):566-8. PubMed ID: 7793735
[TBL] [Abstract][Full Text] [Related]
25. Tranexamic acid (Cyklokapron) is not necessary to reduce blood loss after coronary artery bypass operations.
Ovrum E; Am Holen E; Abdelnoor M; Oystese R; Ringdal ML
J Thorac Cardiovasc Surg; 1993 Jan; 105(1):78-83. PubMed ID: 8419712
[TBL] [Abstract][Full Text] [Related]
26. Which may be effective to reduce blood loss after cardiac operations in cyanotic children: tranexamic acid, aprotinin or a combination?
Bulutcu FS; Ozbek U; Polat B; Yalçin Y; Karaci AR; Bayindir O
Paediatr Anaesth; 2005 Jan; 15(1):41-6. PubMed ID: 15649162
[TBL] [Abstract][Full Text] [Related]
27. A randomized, double-blind, and placebo-controlled study with tranexamic acid of bleeding and fibrinolytic activity after primary coronary artery bypass grafting.
Santos AT; Kalil RA; Bauemann C; Pereira JB; Nesralla IA
Braz J Med Biol Res; 2006 Jan; 39(1):63-9. PubMed ID: 16400465
[TBL] [Abstract][Full Text] [Related]
28. [Effect of tranexamic acid on postoperative bleeding in pediatric heart surgery].
Varela Crespo CA; Sanabria Carretero P; Palomero Rodríguez MA; Tormo las de Heras C; Rodríguez Pérez E; Goldman Tarlousky L
Rev Esp Anestesiol Reanim; 2007 Mar; 54(3):155-61. PubMed ID: 17436653
[TBL] [Abstract][Full Text] [Related]
29. Does tranexamic acid decrease bleeding in patients undergoing cardiopulmonary bypass?
Connelly NR; Kiessling BM; Brull SJ
Yale J Biol Med; 1994; 67(5-6):265-8. PubMed ID: 8579642
[TBL] [Abstract][Full Text] [Related]
30. Effects of cell saver autologous blood transfusion on blood loss and homologous blood transfusion requirements in patients undergoing cardiac surgery on- versus off-cardiopulmonary bypass: a randomised trial.
Niranjan G; Asimakopoulos G; Karagounis A; Cockerill G; Thompson M; Chandrasekaran V
Eur J Cardiothorac Surg; 2006 Aug; 30(2):271-7. PubMed ID: 16829083
[TBL] [Abstract][Full Text] [Related]
31. Infusion of autologous platelet rich plasma does not reduce blood loss and product use after coronary artery bypass. A prospective, randomized, blinded study.
Tobe CE; Vocelka C; Sepulvada R; Gillis B; Nessly M; Verrier ED; Hofer BO
J Thorac Cardiovasc Surg; 1993 Jun; 105(6):1007-13; discussion 1013-4. PubMed ID: 8501929
[TBL] [Abstract][Full Text] [Related]
32. Tranexamic acid reduces transfusions and mediastinal drainage in repeat cardiac surgery.
Shore-Lesserson L; Reich DL; Vela-Cantos F; Ammar T; Ergin MA
Anesth Analg; 1996 Jul; 83(1):18-26. PubMed ID: 8659732
[TBL] [Abstract][Full Text] [Related]
33. [Comparative effect of tranexamic acid on the reduction of bleeding during and after cardiac surgery].
Okuyama K; Matsukawa T; Abe F; Kumazawa T
Masui; 1998 Jul; 47(7):861-4. PubMed ID: 9720336
[TBL] [Abstract][Full Text] [Related]
34. Postoperative bleeding in cardiac surgery: the role of tranexamic acid in patients homozygous for the 5G polymorphism of the plasminogen activator inhibitor-1 gene.
Iribarren JL; Jimenez JJ; Hernández D; Brouard M; Riverol D; Lorente L; de La Llana R; Nassar I; Perez R; Martinez R; Mora ML
Anesthesiology; 2008 Apr; 108(4):596-602. PubMed ID: 18362590
[TBL] [Abstract][Full Text] [Related]
35. Effects of preoperative aspirin and clopidogrel therapy on perioperative blood loss and blood transfusion requirements in patients undergoing off-pump coronary artery bypass graft surgery.
Shim JK; Choi YS; Oh YJ; Bang SO; Yoo KJ; Kwak YL
J Thorac Cardiovasc Surg; 2007 Jul; 134(1):59-64. PubMed ID: 17599487
[TBL] [Abstract][Full Text] [Related]
36. Tranexamic acid is effective in decreasing postoperative bleeding and transfusions in primary coronary artery bypass operations: a double-blind, randomized, placebo-controlled trial.
Brown RS; Thwaites BK; Mongan PD
Anesth Analg; 1997 Nov; 85(5):963-70. PubMed ID: 9356085
[TBL] [Abstract][Full Text] [Related]
37. Coronary artery bypass grafting after aprotinin: are we doing better?
Beckerman Z; Shopen Y; Alon H; Cohen O; Nir RR; Adler Z; Bolotin G
J Thorac Cardiovasc Surg; 2013 Jan; 145(1):243-8. PubMed ID: 23072702
[TBL] [Abstract][Full Text] [Related]
38. Tranexamic acid in primary CABG surgery: high vs low dose.
Armellin G; Vinciguerra A; Bonato R; Pittarello D; Giron GP
Minerva Anestesiol; 2004 Mar; 70(3):97-107. PubMed ID: 14997082
[TBL] [Abstract][Full Text] [Related]
39. The impact of aprotinin on blood loss and blood transfusion in off-pump coronary artery bypass grafting.
Bittner HB; Lemke J; Lange M; Rastan A; Mohr FW
Ann Thorac Surg; 2008 May; 85(5):1662-8. PubMed ID: 18442562
[TBL] [Abstract][Full Text] [Related]
40. Beneficial effect of both tranexamic acid and aprotinin on blood loss reduction in reoperative valve replacement surgery.
Jamieson WR; Dryden PJ; O'Connor JP; Sadeghi H; Ansley DM; Merrick PM
Circulation; 1997 Nov; 96(9 Suppl):II-96-100; discussion II-100-1. PubMed ID: 9386082
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
